DIA Stock News 164.61 05/18/2014 17:57:03 SPDR DOW 30 ETF (D

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPDR DOW 30 ETF (DIA) 164.61 $DIA

Is This Online Start-Up the Secret to Investing Success?
Jason Hall, The Motley Fool - Motley Fool - Sat May 17, 11:00AM CDT
If you've done much reading about investing, you've probably seen the statistics about how few investors actually beat the market. The thing is, one of the reasons investors struggle to beat the market is how bad we are at making predictions about...

Avoid the Growling Small Cap Bear -- Trade These ETFs
at The Street - Fri May 16, 12:10PM CDT
Even with Dow Industrials, the S&P 500 and Dow Transports setting new all-time intraday highs this week, the Nasdaq lags, and the Russell 2000 remains a drag.

Bonds Are Outperforming Stocks This Year
at The Street - Thu May 15, 7:59AM CDT
It's the opposite of what Wall Street analysts predicted at the beginning of the year as Treasuries have outpaced stocks.

A Bifurcated Market in Two Charts - Real Time Insight
Todd Bunton - Zacks Investment Research - Wed May 14, 1:54PM CDT
The tortoise is beating the hare so far this year.

Choppy Market? Swing Trade Ideas for Monday
at The Street - Mon May 05, 9:58AM CDT
In this up-and-down market, traders need to watch positions carefully and be ready for anything.

Do These 3 Things, and You May Retire Rich
Jason Hall, The Motley Fool - Motley Fool - Sat May 03, 11:00AM CDT
"Compound interest is the eighth wonder of the world. He who understands it, earns it. He who doesn't, pays it." --Attributed to Albert Einstein Gold Price in U.S. Dollars data by YCharts . That's 30-plus years of evidence that...

Jobs Report Weighs Heavy on Dems, GOP for Midterms
at The Street - Fri May 02, 1:49PM CDT
The jobs report is already influencing the midterm elections.

5 Things to Watch For in the Jobs Report - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu May 01, 9:51PM CDT
What should investors be on the lookout for in the key jobs report?

Investors Should Take Calm From the Latest Fed Statement
at The Street - Thu May 01, 4:00AM CDT
Investors received calming news from the latest Federal Reserve statement.

QE Taper Remains on Track - Real Time Insight
Neena Mishra - Zacks Investment Research - Wed Apr 30, 2:29PM CDT
This was the fourth consecutive cut in the QE3 program.

SmarTrend Watching for Potential Pullback in Shares of DIAMONDS Trust Series I After 1.02% Gain
Comtex SmarTrend(R) - Wed Apr 16, 3:50PM CDT
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $162.93 to a high of $164.03. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $162.47 on volume of 5.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of DIAMONDS Trust Series I to Potentially Pullback after Yesterday's 1.02% Rise
Comtex SmarTrend(R) - Wed Apr 16, 3:50PM CDT
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $162.93 to a high of $164.03. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $162.47 on volume of 5.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Jim Cramer's Bull Case for This Market
at The Street - Fri Apr 11, 3:18PM CDT
TheStreet's Jim Cramer says in his trading history when investors think it's obvious that the market would go down, it tends to move in the other direction. Cramer says it is still early and investors should be careful. He points out high-fliers...

Bitcoin--The Worst Investment in the World? - Real Time Insight
Neena Mishra - Zacks Investment Research - Wed Apr 09, 2:38PM CDT
After a disastrous performance this year so far,can the digital currency survive and thrive?

After Yesterday's Decline of 1.05%, DIAMONDS Trust Series I Offers Investors Better Value
Comtex SmarTrend(R) - Mon Apr 07, 3:49PM CDT
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $162.12 to a high of $163.93. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $163.58 on volume of 8.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

DIAMONDS Trust Series I Set to Possibly Rebound After Yesterday's Selloff of 1.05%
Comtex SmarTrend(R) - Mon Apr 07, 3:49PM CDT
DIAMONDS Trust Series I (AMEXIA) traded in a range yesterday that spanned from a low of $162.12 to a high of $163.93. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $163.58 on volume of 8.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Is This the Spring Thaw? - Ahead of Wall Street
Sheraz Mian - Zacks Investment Research - Fri Apr 04, 9:22AM CDT
Q1 is expected to be the low-point for the year, with growth expected to steadily improve from Q2 onwards.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 111

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 78

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 170

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 103

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 55

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
HearUSA Expands Access with AI-Powered Hearing Aids

Updated Category News Views 161

AI Revolution in Hearing Care Look, the hearing aid industry isn't known for headlines that grab you by the throat, but HearUSA just tossed a proverbial grenade into the scene with Widex Allure AI RIC. This is more than a slight tweak in hearing tech—it's a game-changer. We're talking about on-demand AI noise management blended with Widex's renowned natural sound. It's...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Apotex Enters U.S. Market with Axitinib Tablets Launch

Updated Category News Views 89

Apotex's Bold Move: Axitinib Tablets Hit the U.S. Market Apotex is shaking things up in the pharma world by launching the first generic version of Axitinib Tablets in the U.S., aimed at treating advanced renal cell carcinoma (RCC) when previous treatments have fallen flat. This isn't just another dance with the red tape—it's a major step for Apotex, flexing their muscle...

Continue Reading
Quantum X and Everest Cloud Partner in South Asia Push

Updated Category News Views 61

An Unlikely Alliance for Cutting-Edge Tech You gotta admit, the fusion of a U.S.-based tech outfit with a Nepalese cloud provider wasn't the market move anyone saw coming. But here we are—Quantum X is hitching its quantum computing dreams to Everest Cloud's solid local foothold across six South Asian markets. We're talking Nepal, India, Bangladesh, Bhutan, Sri Lanka,...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 120

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading

Top 5 Most Recently Viewed Articles

Gap Inc. Sees Minor Sales Growth Amid Market Challenges

Updated Category News Views 254

Gap Inc. Experiences Modest Growth Gap Inc. demonstrated resilience in a challenging market, achieving a 1% increase in net sales compared to the previous year. The comparable sales rose by 3%, reflecting the brand's enhancement strategies. Brand Performance Highlight Each of Gap Inc.'s four major brands—Old Navy, Gap, Banana Republic, and Athleta—gained market share,...

Continue Reading
Innovative Lock Design Enhances Security for Commercial Trailers

Updated Category News Views 761

The SMART LOC: A Game-Changer for Trucking Security In a world where cargo theft is a persistent challenge, the development of an innovative solution is essential. Enter the SMART LOC, a new locking mechanism designed specifically for commercial trailers. This invention aims to significantly enhance security for trucking professionals, ultimately providing much-needed...

Continue Reading
GXO Logistics Prepares for First Quarter Earnings Call Soon

Updated Category News Views 198

GXO Logistics Set for First Quarter Earnings Presentation GXO Logistics, Inc. (NYSE: GXO) is preparing for its first quarter earnings conference call, which is scheduled for May 8, 2025, at 8:30 a.m. Eastern Time. During this call, the company will share its financial results and key insights into its business performance. Interested participants are encouraged to join in...

Continue Reading
Legal Action Against Everus Construction Group for Investors

Updated Category News Views 132

Overview of Legal Proceedings Against Everus Construction Group Everus Construction Group, Inc. (NYSE: ECG) is currently facing significant legal challenges as a result of alleged securities law violations. The situation has prompted attention from shareholders and investors alike. The Gross Law Firm has taken the initiative to notify shareholders regarding this serious...

Continue Reading
Nxera Pharma and Cancer Research UK Collaborate to Combat Cancer

Updated Category News Views 121

Nxera Pharma Joins Forces with Cancer Research UK for Innovative Trials HTL0039732, a promising oral EP4 antagonist developed by Nxera, shows potential in tackling various types of cancer, especially when paired with leading immunotherapies. Currently, this drug is making progress through its Phase 1/2a clinical trials, highlighting its potential effectiveness across a...

Continue Reading